1. Home
  2. VABK vs MIST Comparison

VABK vs MIST Comparison

Compare VABK & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$40.57

Market Cap

215.8M

Sector

Finance

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.67

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
MIST
Founded
1998
2003
Country
US
US
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.8M
176.3M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
VABK
MIST
Price
$40.57
$1.67
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
4.6K
1.9M
Earning Date
04-30-2026
02-22-2026
Dividend Yield
3.58%
N/A
EPS Growth
N/A
51.80
EPS
2.45
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.56
$0.63
52 Week High
$44.50
$3.06

Technical Indicators

Market Signals
Indicator
VABK
MIST
Relative Strength Index (RSI) 46.27 33.58
Support Level $39.78 $1.70
Resistance Level $43.34 $1.89
Average True Range (ATR) 1.06 0.09
MACD -0.20 -0.01
Stochastic Oscillator 10.93 3.47

Price Performance

Historical Comparison
VABK
MIST

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: